Literature DB >> 20049450

Perforin level in CD4+ T cells from patients with systemic lupus erythematosus.

Anna Kozłowska1, Paweł Hrycaj, Jan K Łącki, Paweł Piotr Jagodziński.   

Abstract

CD4(+) T cells from patients with systemic lupus erythematosus (SLE) exhibit increased expression of various proteins contributing to defective function of CD4(+) T cells. We evaluated the transcript and protein levels of perforin (PRF1) in CD4(+) T cells from SLE patients (n = 41) and healthy individuals (n = 34). The CD4(+) T cells were obtained by a positive biomagnetic separation system. The amounts of mRNA were determined by reverse transcription and real-time quantitative PCR. The protein levels in the CD4(+) T cells were evaluated by Western blotting analysis. We observed significantly higher levels of PRF1 protein (p = 0.013) in SLE CD4(+) T cells than in controls. There was no significant increase in PRF1 transcript levels (p = 0.908) in CD4(+) T cells from SLE patients as compared to healthy individuals. Moreover, we did not observe a correlation between PRF1 transcript and protein levels in SLE CD4(+) T cells and disease activity expressed by the SLEDAI scale. We confirmed previous observations that demonstrated higher levels of PRF1 protein in CD4(+) T cells from SLE patients. However, we did not find a correlation between PRF1 transcripts and proteins in CD4(+) T cells and SLE disease activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049450     DOI: 10.1007/s00296-009-1329-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  42 in total

Review 1.  Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

Authors:  P J Utz; P Anderson
Journal:  Arthritis Rheum       Date:  1998-07

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury.

Authors:  M Nakajima; A Nakajima; N Kayagaki; M Honda; H Yagita; K Okumura
Journal:  Clin Immunol Immunopathol       Date:  1997-06

4.  Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients.

Authors:  Chun Fu Zheng; Ling Ling Ma; Gareth J Jones; M John Gill; Alan M Krensky; Paul Kubes; Christopher H Mody
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

7.  Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.

Authors:  Taku Kobayashi; Susumu Okamoto; Yuko Iwakami; Atsushi Nakazawa; Tadakazu Hisamatsu; Hiroshi Chinen; Nobuhiko Kamada; Toshio Imai; Hidemi Goto; Toshifumi Hibi
Journal:  Inflamm Bowel Dis       Date:  2007-07       Impact factor: 5.325

Review 8.  DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.

Authors:  Ying Zhou; Qianjin Lu
Journal:  Autoimmun Rev       Date:  2008-04-04       Impact factor: 9.754

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis.

Authors:  Andreas E R Fasth; Omri Snir; Anna A T Johansson; Birgitta Nordmark; Afsar Rahbar; Erik Af Klint; Niklas K Björkström; Ann-Kristin Ulfgren; Ronald F van Vollenhoven; Vivianne Malmström; Christina Trollmo
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  4 in total

1.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 2.  Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Expert Rev Clin Immunol       Date:  2015-01       Impact factor: 4.473

3.  DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis.

Authors:  Puleng Matatiele; Mohamed Tikly; Gareth Tarr; Mary Gulumian
Journal:  J Biomed Sci       Date:  2015-05-20       Impact factor: 8.410

Review 4.  The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Authors:  Haijing Wu; Yongjian Chen; Huan Zhu; Ming Zhao; Qianjin Lu
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.